Craft

Vimian Group

Stock Price

KR28.5

2024-02-09

Market Capitalization

KR13.2 B

2024-02-09

Revenue

€281.3 M

FY, 2022

Vimian Group Summary

Company Summary

Overview
Vimian Group is a provider of animal health services. It specializes in proprietary diagnostics, prescription and non-prescription treatments, procurement, tech-driven operations applications, etc. The company also offers molecular and immunodiagnostic solutions.
Type
Public
Status
Active
Founded
2021
HQ
Stockholm, SE | view all locations
Website
https://vimian.com/
Sectors

LocationsView all

1 location detected

  • Stockholm, Stockholms län HQ

    Sweden

    Riddargatan 19

Vimian Group Financials

Summary Financials

Revenue (Q3, 2023)
€79.9M
Gross profit (Q3, 2023)
€54.2M
Net income (Q3, 2023)
€7.6M
Cash (Q3, 2023)
€49.3M
EBIT (Q3, 2023)
€9.9M
Enterprise value
$13.5B

Footer menu